DEFA14A: BlackRock Health Sciences Term Trust Responds to Shareholder Concerns

BlackRock addresses concerns regarding proxy voting and shareholder access in its Health Sciences Term Trust.

Summary

• BlackRock Advisors, LLC issued statements addressing concerns related to proxy voting and shareholder access within the BlackRock Health Sciences Term Trust.
• BlackRock clarifies that non-votes are not counted as votes in favor of BlackRock nominees.
• The company emphasizes that significant changes to the Board require affirmative votes from a majority of shareholders.
• BlackRock welcomes constructive engagement with shareholders who aim to enhance long-term value.
• BlackRock highlights its history of taking actions, such as discount management programs and mergers, to improve returns for closed-end funds.
• BlackRock asserts that it has always complied with applicable laws regarding shareholder information access and has not blocked Sabas' access to shareholders.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. BlackRock is defending its actions and emphasizing its commitment to shareholder value, but the need to address concerns suggests underlying issues.

Positives

• BlackRock welcomes constructive engagement with shareholders who act in good faith.
• The company has a history of taking actions to improve returns of closed-end funds.
• BlackRock asserts compliance with all applicable laws regarding shareholder information access.

Risks

• Potential for continued disagreement with dissident investors regarding the best course of action for the fund.
• Risk of shareholder dissatisfaction if discount management programs and mergers do not yield desired results.

Future Outlook

The document does not provide a specific future outlook, but implies a commitment to improving shareholder value and engaging with shareholders constructively.

Management Comments

• It is very misleading to say that non-votes count as votes for BlackRock nominees.
• BlackRocks closed-end funds welcome constructive engagement with thoughtful shareholders who act in good faith with the shared goal of enhancing long-term value for all.
• BlackRock has taken numerous actions over the years, including discount management programs and mergers, to improve returns of our closed-end funds where we felt these actions were in the best interest of shareholders.
• We have never blocked Sabas access to shareholders.

Industry Context

This announcement reflects the increasing pressure on investment firms to be transparent and responsive to shareholder concerns, particularly in the context of closed-end funds where discount management is a key issue.

Comparison to Industry Standards

• BlackRock's engagement with shareholders is consistent with industry best practices for corporate governance.
• Other asset managers like Vanguard and State Street also emphasize shareholder engagement and transparency.
• Discount management programs are a common strategy employed by closed-end funds to improve shareholder value, with examples including similar initiatives by Eaton Vance and Nuveen.

Stakeholder Impact

• Shareholders: Aims to reassure shareholders about the integrity of the voting process and BlackRock's commitment to enhancing long-term value.
• Employees: Reinforces the company's commitment to acting in accordance with applicable laws.
• Dissident Investors: Addresses their concerns and clarifies BlackRock's position on key issues.

Keywords

BlackRock, Health Sciences Term Trust, proxy statement, shareholder access, non-votes, discount management, mergers, corporate governance